|
^ HTBX: Intraday Hourly Forecast Similar Waves GapOpen Research Timing Gains Losses Strategies Practice |
Thu. Dec. 14, 2017 | Trading Signals: HTBX Stock Price Prediction and Forecast (Mon. Dec. 28, 2015 - Mon. May. 2, 2022)(Heat Biologics, Inc.)
| HTBX latest price $26.1800 (1.6%) ($25.0460 - $28.0000) on Thu. Dec. 14, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.35% (three month average) | RSI | 37 | Latest Price | $26.1800(1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HTBX declines -1.6% a day on average for past five trading days. | Weekly Trend | HTBX declines -10.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HTBX advance at 0% a week (0% probability) ARKK(8%) KWEB(8%) MCHI(8%) QQQ(8%) SKYY(8%) | Factors Impacting HTBX price | HTBX will decline at least -2.175% in a week (0% probabilities). VCSH(-9%) VIXM(-5%) CEMB(-5%) BNDX(-4%) XLU(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.175% (StdDev 4.35%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $7.05(-73.07%) | Resistance Level | $30.14 | 5 Day Moving Average | $26.01(0.65%) | 10 Day Moving Average | $27.74(-5.62%) | 20 Day Moving Average | $30.14(-13.14%) | To recent high | -50.7% | To recent low | 6.8% | Market Cap | $2.88b | | | | Heat Biologics, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in Morrisville, NC. | $. HTBX price fluctuates within 11.15% (three month std-dev: 4.35%) daily (68% of days). Sample size 3 Average positive next day return: 7.51%(33%) Average negative next day return: -3.08%(67%)
Sample size 3 Average positive next three day return: 0%(0%) Average negative next three day return: -3.72%(100%)
Sample size 3 Average positive next weekly return: 0%(0%) Average negative next weekly return: -11.46%(100%)
Analysis News Options Weekly Chart Daily Chart 2 Month Daily Chart > 20180114 i | Date | ema100 | ema20 | ema10 | ema5 | Slow Hourly Trend | Fast Hourly Trend | Close | Pattern | Trade | P | SMA5 BBV | WTF | lsma10 Trend | ema5 Trend | ema10 Trend | Volume millions | Quarterly Strength | 100 Daily Trend | Daily Trend Force | Daily StdDev | Hourly BBV | BBV | RSI | VIXCD |
---|
|
|